Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Composition of health care product for auxiliary treatment of pelvic effusion

A technology for adjuvant treatment and pelvic effusion, applied in the direction of drug combination, medical preparations containing active ingredients, drug delivery, etc., can solve problems such as infertility, tubal blockage, and reduce the quality of life of patients, achieving obvious therapeutic effects and effective obvious effect

Inactive Publication Date: 2018-10-09
金寨县鑫和新能源科技有限公司
View PDF10 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Pathological pelvic effusion occurs after pelvic inflammatory disease, adnexitis or endometriosis; pelvic effusion leads to decreased resistance, menstrual disorders, and clinical examination reveals that pelvic inflammatory disease leads to blockage of fallopian tubes, retroverted uterus, uterine Activities are limited, or adhesions occur, resulting in infertility. Modern medicine treats such diseases when the efficacy of drugs is not obvious, and even surgery is used for treatment. The risk of surgery and the pain of the treatment process reduce the pain of patients. quality of life, surgery itself carries great risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] A composition of health products for auxiliary treatment of pelvic effusion according to the present invention, biological compound enzyme 0.1g; red algae extract: 5g; brown algae extract: 4g; propolis: 3g; calcidol: 5g; lemon extract: 12g ; Add 32g of additives to make suppositories; the average weight of the suppositories is about 1.7g.

[0025] There were 10 people in the experimental group and 10 people in the control group. The drug was used at the same time. The recovery of the experimental group was obvious and the treatment results were stable. The disease course of the control group was obviously longer and repeated.

Embodiment 2

[0027] Biological compound enzyme: 0.6g; red algae extract: 7g; brown algae extract: 3g; propolis: 4g; , the average weight of the capsule is about 1.7g;

[0028] There were 10 people in the experimental group and 10 people in the control group. The drug was used at the same time. The recovery of the experimental group was obvious and the treatment results were stable. The disease course of the control group was obviously longer and repeated.

Embodiment 3

[0030] Biological compound enzyme: 0.7g; Red algae extract: 5g; Brown algae extract 5g; Propolis 4g; Calciferol 4g; Lemon extract 11g; Treatment of vaginitis, pelvic inflammatory disease;

[0031] There were 10 people in the experimental group and 10 people in the control group. The drug was used at the same time. The recovery of the experimental group was obvious and the treatment results were stable. The disease course of the control group was obviously longer and repeated.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a composition of a health care product for auxiliary treatment of pelvic effusion. The composition is prepared from the following components in parts by mass: 0.1-1 part of biological complex enzyme, 3-7 parts of red alga extract, 2-5 parts of brown alga extract, 1-4 parts of bee glue, 2-5 parts of calciferol, 5-12 parts of lemon extract and 30-35 parts of additive. By adopting the technical scheme disclosed by the invention, the composition of the health care product for auxiliary treatment of pelvic effusion can be synergistic with other drugs to obtain very obvious treatment effects.

Description

technical field [0001] The invention belongs to the field of biological preparations, more specifically, the invention relates to a composition of health care products for auxiliary treatment of pelvic effusion. Background technique [0002] Pathological pelvic effusion occurs after pelvic inflammatory disease, adnexitis or endometriosis; pelvic effusion leads to decreased resistance, menstrual disorders, and clinical examination reveals pelvic inflammatory disease leading to blockage of fallopian tubes, retroverted uterus, uterine Activities are limited, or adhesions occur, resulting in infertility. Modern medicine treats such diseases when the efficacy of drugs is not obvious, and even surgery is used for treatment. The risk of surgery and the pain of the treatment process reduce the pain of patients. quality of life, surgery itself carries great risks. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a composi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/47A61P15/00A61P15/02A61P35/00A61K38/44A61K36/752A61K35/644A61K31/592
CPCA61K9/0031A61K9/0034A61K31/592A61K35/644A61K36/03A61K36/04A61K36/752A61K38/44A61K38/47A61P15/00A61P15/02A61P35/00C12Y302/01C12Y302/01017A61K2300/00
Inventor 何苗
Owner 金寨县鑫和新能源科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com